Psychotropic drug and polypharmacy use among adolescents and young adults: Findings from the Finnish 1981 Nationwide Birth Cohort Study

References

• Verdoux H, Tournier M, Begaud B. Antipsychotic prescribing trends: A review of pharmaco-epidemiological studies. Acta Psychiatr Scand 2010;121:4–10.
   PubMed Web of Science ®Google Scholar
• Olfson M, Marcus SC. National patterns in antidepressant medication treatment. Arch Gen Psychiatry 2009;66:848–56.
   PubMed Web of Science ®Google Scholar
• Zoega H, Baldursson G, Hrafnkelsson B, Almarsdottir AB, Valdimarsdottir U, Halldorsson M. Psychotropic drug use among Icelandic children: A nationwide population-based study. J Child Adolesc Psychopharmacol 2009;19:757–64.
   PubMed Web of Science ®Google Scholar
• Martin A, Leslie D. Psychiatric inpatient, outpatient, and medication utilization and costs among privately insured youths, 1997–2000. Am J Psychiatry 2003;160:757–64.
   PubMed Web of Science ®Google Scholar
• Schirm E, Tobi H, Zito JM, de Jong-van den Berg LT. Psychotropic medication in children: A study from the Netherlands. Pediatrics 2001;108:E25.
   PubMed Web of Science ®Google Scholar
• Rani F, Murray ML, Byrne PJ, Wong IC. Epidemiologic features of antipsychotic prescribing to children and adolescents in primary care in the United Kingdom. Pediatrics 2008;121:1002–9.
   PubMed Web of Science ®Google Scholar
• Cooper WO, Hickson GB, Fuchs C, Arbogast PG, Ray WA. New users of antipsychotic medications among children enrolled in TennCare. Arch Pediatr Adolesc Med 2004;158:753–9.
   PubMed Web of Science ®Google Scholar
• Clark AF. Incidences of new prescribing by British child and adolescent psychiatrists: A prospective study over 12 months. J Psychopharmacol 2004;18:115–20.
   PubMed Web of Science ®Google Scholar
• Barsky AJ. Forgetting, fabricating, and telescoping: The instability of the medical history. Arch Intern Med 2002;162:981–4.
   PubMedGoogle Scholar
• Preskorn SH. Pharmacogenomics, informatics, and individual drug therapy in psychiatry: Past, present and future. J Psychopharmacol 2006;20(4 Suppl):85–94.
   PubMedGoogle Scholar
• Comer JS, Olfson M, Mojtabai R. National trends in child and adolescent psychotropic polypharmacy in office-based practice, 1996–2007. J Am Acad Child Adolesc Psychiatry 2010;49:1001–10.
   PubMed Web of Science ®Google Scholar
• Mojtabai R, Olfson M. National trends in psychotropic medication polypharmacy in office-based psychiatry. Arch Gen Psychiatry 2010;67:26–36.
   PubMed Web of Science ®Google Scholar
• Mancini J, Thirion X, Masut A, Saillard C, Pradel V, Romain F, . Anxiolytics, hypnotics, and antidepressants dispensed to adolescents in a French region in 2002. Pharmacoepidemiol Drug Saf 2006;15:494–503.
   PubMed Web of Science ®Google Scholar
• Zito JM, Safer DJ, Berg LT, Janhsen K, Fegert JM, Gardner JF, . A three-country comparison of psychotropic medication prevalence in youth. Child Adolesc Psychiatry Ment Health 2008;2:26.
   PubMedGoogle Scholar
• Fourrier A, Gasquet I, Allicar MP, Bouhassira M, Lepine JP, Begaud B. Patterns of neuroleptic drug prescription: A national cross-sectional survey of a random sample of French psychiatrists. Br J Clin Pharmacol 2000;49:80–6.
   PubMed Web of Science ®Google Scholar
• Gilat Y, Ben-Dor DH, Magen A, Wolovick L, Vekslerchik M, Weizman A, . Trends in prescribing of psychotropic medications for inpatient adolescents in Israel: A 10 years retrospective analysis. Eur Psychiatry 2011;26:265–9.
   PubMedGoogle Scholar
• Sourander A. Combined psychopharmacological treatment among child and adolescent inpatients in Finland. Eur Child Adolesc Psychiatry 2004;13:179–84.
   PubMedGoogle Scholar
• Dean AJ, McDermott BM, Marshall RT. Psychotropic medication utilization in a child and adolescent mental health service. J Child Adolesc Psychopharmacol 2006;16:273–85.
   PubMed Web of Science ®Google Scholar
• Jordanova V, Maric NP, Alikaj V, Bajs M, Cavic T, Iosub D, . Prescribing practices in psychiatric hospitals in Eastern Europe. Eur Psychiatry 2010; Epub ahead of print Sep 7.
   PubMedGoogle Scholar
• Gyllenberg D, Sourander A, Niemel S, Helenius H, Sillanm ki L, Ristkari T, . Childhood predictors of use and costs of antidepressant medication by age 24 years: Findings from the Finnish nationwide 1981 birth cohort study. J Am Acad Child Adolesc Psychiatry 2011;50:406–15.
   PubMedGoogle Scholar
• Almqvist F, Ikäheimo K, Kumpulainen K, Tuompo-Johansson E, Linna SL, Puura K, . Design and subjects of a Finnish epidemiological study on psychiatric disorders in childhood. Eur Child Adolesc Psychiatry 1999;8 Suppl 4:3–6.
   PubMed Web of Science ®Google Scholar
• Sourander A, Ronning J, Brunstein-Klomek A, Gyllenberg D, Kumpulainen K, Niemelä S, . Childhood bullying behavior and later psychiatric hospital and psychopharmacologic treatment: Findings from the Finnish 1981 birth cohort study. Arch Gen Psychiatry 2009;66:1005–12.
   PubMed Web of Science ®Google Scholar
• National Social Insurance Institution. Statistical Yearbook, the Social Insurance Institution. 2007; Available at: http//www.kela.fi/it/kelasto/kelasto.nsf/alias/Vk_06_pdf. Accessed April 5, 2010.
   Google Scholar
• Martin A, Van Hoof T, Stubbe D, Sherwin T, Scahill L. Multiple psychotropic pharmacotherapy among child and adolescent enrollees in Connecticut Medicaid managed care. Psychiatr Serv 2003;54:72–7.
   PubMed Web of Science ®Google Scholar
• Zito JM, Safer DJ. Recent child pharmacoepidemiological findings. J Child Adolesc Psychopharmacol 2005;15:5–9.
   PubMed Web of Science ®Google Scholar
• Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457–81.
   Web of Science ®Google Scholar
• Cox DR. Regression models and life-tables. J R Stat Soc Ser B (Methodological) 1972;34:187–220.
   Web of Science ®Google Scholar
• Autti-Rämö I, Seppänen J, Raitasalo R, Martikainen JE, Sourander A. Increase in use of psychotropics among adolescents and young adults since the beginning of the 21st century. Suomen Lääkärilehti (Finnish Medical Journal) 2009;64:477–82.
   Google Scholar
• Vitiello B, Zuvekas SH, Norquist GS. National estimates of antidepressant medication use among U.S. children, 1997–2002. J Am Acad Child Adolesc Psychiatry 2006;45:271–9.
   PubMed Web of Science ®Google Scholar
• Patel NC, Crismon ML, Hoagwood K, Johnsrud MT, Rascati KL, Wilson JP, . Trends in the use of typical and atypical antipsychotics in children and adolescents. J Am Acad Child Adolesc Psychiatry 2005;44:548–56.
   PubMed Web of Science ®Google Scholar
• Zoega H, Furu K, Halldorsson M, Thomsen PH, Sourander A, Martikainen JE. Use of ADHD drugs in the Nordic countries: A population-based comparison study. Acta Psychiatr Scand 2011;123:360–7.
   PubMed Web of Science ®Google Scholar
• Paus T, Keshavan M, Giedd JN. Why do many psychiatric disorders emerge during adolescence? Nat Rev Neurosci 2008;9:947–57.
   PubMed Web of Science ®Google Scholar
• Kessler RC, Olfson M, Berglund PA. Patterns and predictors of treatment contact after first onset of psychiatric disorders. Am J Psychiatry 1998;155:62–9.
   PubMed Web of Science ®Google Scholar
• Autti-Rämö I, Sourander A, Seppänen J, Martikainen JE. Use of antidepressants among 0–26 year olds in Finland during 1997–2007. Eur J Psychiat 2011;25:164–72.
   Google Scholar
• Anderson IM, Ferrier IN, Baldwin RC, Cowen PJ, Howard L, Lewis G, . Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2000 British Association for Psychopharmacology guidelines. J Psychopharmacol 2008;22:343–96.
   PubMed Web of Science ®Google Scholar
• Hoffman EJ, Mathew SJ. Anxiety disorders: A comprehensive review of pharmacotherapies. Mt Sinai J Med 2008;75:248–62.
   PubMed Web of Science ®Google Scholar
• Brent DA, Emslie GJ, Clarke GN, Asarnow J, Spirito A, Ritz L, . Predictors of spontaneous and systematically assessed suicidal adverse events in the treatment of SSRI-resistant depression in adolescents (TORDIA) study. Am J Psychiatry 2009;166:418–26.
   PubMed Web of Science ®Google Scholar
• Zanarini MC, Frankenburg FR, Hennen J, Silk KR. Mental health service utilization by borderline personality disorder patients and Axis II comparison subjects followed prospectively for 6 years. J Clin Psychiatry 2004;65:28–36.
   PubMed Web of Science ®Google Scholar
• Thase ME. Bipolar depression: Issues in diagnosis and treatment. Harv Rev Psychiatry 2005;13:257–71.
   PubMed Web of Science ®Google Scholar
• Zink M, Englisch S, Meyer-Lindenberg A. Polypharmacy in schizophrenia. Curr Opin Psychiatry 2010;23:103–11.
   PubMed Web of Science ®Google Scholar
• Wine JN, Sanda C, Caballero J. Effects of quetiapine on sleep in nonpsychiatric and psychiatric conditions. Ann Pharmacother 2009;43:707–13.
   PubMedGoogle Scholar
• Schwartz S, Diez Roux AV, Susser E. Causal explanation outside the black box. In: Susser E, Schwartz S, Morabia A, Bromet Eeditors. Psychiatric epidemiology. New York: Oxford Scholarship Online Monographs; 2006. p. 441–61.
   Google Scholar
• Fisher RL, Fisher S. Antidepressants for children. Is scientific support necessary? J Nerv Ment Dis 1996;184:99–102.
   PubMed Web of Science ®Google Scholar
• Sourander A. Risperidone for treatment of childhood schizophrenia. Am J Psychiatry 1997;154:1476.
   PubMedGoogle Scholar
• Bryden KE, Carrey NJ, Kutcher SP. Update and recommendations for the use of antipsychotics in early-onset psychoses. J Child Adolesc Psychopharmacol 2001;11:113–30.
   PubMed Web of Science ®Google Scholar